Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
We used ultra-deep sequencing to obtain tens of thousands of HIV-1 sequences from regions targeted by CD8+ T lymphocytes from longitudinal samples from three acutely infected subjects, and modeled viral evolution during the critical first weeks of infection. Previous studies suggested that a single virus established productive infection, but these conclusions were tempered because of limited sampling; now, we have greatly increased our confidence in this observation through modeling the observed earliest sample diversity based on vastly more extensive sampling. Conventional sequencing of HIV-1 from acute/early infection has shown different patterns of escape at different epitopes; we investigated the earliest escapes in exquisite detail. Over 3-6 weeks, ultradeep sequencing revealed that the virus explored an extraordinary array of potential escape routes in the process of evading the earliest CD8 T-lymphocyte responses--using 454 sequencing, we identified over 50 variant forms of each targeted epitope during early immune escape, while only 2-7 variants were detected in the same samples via conventional sequencing. In contrast to the diversity seen within epitopes, non-epitope regions, including the Envelope V3 region, which was sequenced as a control in each subject, displayed very low levels of variation. In early infection, in the regions sequenced, the consensus forms did not have a fitness advantage large enough to trigger reversion to consensus amino acids in the absence of immune pressure. In one subject, a genetic bottleneck was observed, with extensive diversity at the second time point narrowing to two dominant escape forms by the third time point, all within two months of infection. Traces of immune escape were observed in the earliest samples, suggesting that immune pressure is present and effective earlier than previously reported; quantifying the loss rate of the founder virus suggests a direct role for CD8 T-lymphocyte responses in viral containment after peak viremia. Dramatic shifts in the frequencies of epitope variants during the first weeks of infection revealed a complex interplay between viral fitness and immune escape.
Fischer
Will
W
Theoretical Biology, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Ganusov
Vitaly V
VV
Giorgi
Elena E
EE
Hraber
Peter T
PT
Keele
Brandon F
BF
Leitner
Thomas
T
Han
Cliff S
CS
Gleasner
Cheryl D
CD
Green
Lance
L
Lo
Chien-Chi
CC
Nag
Ambarish
A
Wallstrom
Timothy C
TC
Wang
Shuyi
S
McMichael
Andrew J
AJ
Haynes
Barton F
BF
Hahn
Beatrice H
BH
Perelson
Alan S
AS
Borrow
Persephone
P
Shaw
George M
GM
Bhattacharya
Tanmoy
T
Korber
Bette T
BT
D016384:Consensus Sequence; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D019143:Evolution, Molecular; D016679:Genome, Viral / Q000235:genetics*; D015658:HIV Infections / Q000276:immunology; D015497:HIV-1 / Q000235:genetics* / Q000276:immunology / Q000502:physiology*; D006801:Humans; D057131:Immune Evasion / Q000235:genetics*; D009154:Mutation; D012641:Selection, Genetic; D017422:Sequence Analysis, DNA; D013997:Time Factors
D000939:Epitopes
J Virol. 2010 Jun;84(11):5802-14
20335256
AIDS Res Hum Retroviruses. 2003 Feb;19(2):145-9
12643277
Genetics. 1943 Nov;28(6):491-511
17247100
Nat Med. 2010 Mar;16(3):324-8
20173754
J Virol. 2008 Aug;82(15):7700-10
18508902
Nat Methods. 2009 Sep;6(9):639-41
19668203
PLoS Comput Biol. 2006 Mar;2(3):e24
16604188
ISME J. 2009 Nov;3(11):1314-7
19587772
AIDS Res Hum Retroviruses. 2009 Mar;25(3):297-303
19327049
J Immunol. 2006 May 15;176(10):6130-46
16670322
J Virol. 1995 Aug;69(8):5087-94
7541846
PLoS One. 2009 May 25;4(5):e5683
19479085
J Virol. 2008 Sep;82(18):9216-27
18614631
J Virol. 2010 Jun;84(12):6241-7
20375173
J Virol. 1994 Sep;68(9):6103-10
8057491
Nature. 2009 Jan 1;457(7225):87-91
18997770
J Exp Med. 2004 Nov 15;200(10):1243-56
15545352
PLoS Pathog. 2007 Jul;3(7):e94
17616974
J Exp Med. 2009 Apr 13;206(4):909-21
19307327
J Virol. 2009 Apr;83(8):3993-7
19091871
J Exp Med. 2009 Jun 8;206(6):1253-72
19487423
J Virol. 2009 Aug;83(16):8247-53
19515775
PLoS Biol. 2006 Apr;4(4):e90
16515366
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1460-5
9465037
Syst Biol. 2003 Oct;52(5):696-704
14530136
Nature. 2005 Sep 15;437(7057):376-80
16056220
J Virol. 2010 Jun;84(12):6218-28
20375170
Science. 1996 Mar 15;271(5255):1582-6
8599114
Nat Med. 1996 Apr;2(4):405-11
8597949
Nat Med. 2010 Mar;16(3):319-23
20173752
Science. 1996 Apr 26;272(5261):537-42
8614801
Nat Med. 2007 Jan;13(1):100-6
17187074
PLoS Pathog. 2009 May;5(5):e1000414
19424423
Curr HIV Res. 2006 Apr;4(2):191-7
16611057
Clin Infect Dis. 2006 May 1;42(9):1333-9
16586394
J Virol. 1994 Nov;68(11):7467-81
7933130
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
18490657
PLoS Pathog. 2010 May 13;6(5):e1000890
20485520
J Virol. 2009 Apr;83(8):3556-67
19193811
Bioinformatics. 2004 Jan 22;20(2):289-90
14734327
J Exp Med. 2009 Jun 8;206(6):1273-89
19487424
Nat Med. 1997 Feb;3(2):205-11
9018240
J Theor Biol. 2009 Nov 21;261(2):341-60
19660475